Adage Capital Partners
RAIN

Adage Capital Partners’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

Adage Capital Partners’s Portfolio RAIN Stock Details RAIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,123,282
Closed -$18.6M – 957
2023
Q1 		$18.6M Buy
2,123,282
+1,450,000
+215% +$13.4M 0.04% 442
2022
Q4 		$5.39M Buy
673,282
+425,000
+171% +$2.67M 0.01% 736
2022
Q3 		$1.21M Buy
248,282
+180,000
+264% +$1.13M ﹤0.01% 882
2022
Q2 		$380K Buy
+68,282
New +$234K ﹤0.01% 947

Other funds holding RAIN

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

Adage Capital Partners's RAIN Position: Q2 2023 in Review

Adage Capital Partners sold out of Rain Oncology Inc. Common Stock (RAIN) in Q2 2023, closing a stake of 2,123,282 shares — an estimated $18.6M sold.

Adage Capital Partners first reported a position in RAIN in Q2 2022 and held it in 4 quarters. The position peaked at $18.6M in Q1 2023. 62 funds tracked by Wall St. Rank hold RAIN as of Q2 2023.

  • Adage Capital Partners reported no remaining Rain Oncology Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Adage Capital Partners sold 2,123,282 Rain Oncology Inc. Common Stock shares in Q2 2023, an estimated $18.6M.
  • Adage Capital Partners first reported a position in Rain Oncology Inc. Common Stock in Q2 2022 and held it in 4 quarters.
  • Adage Capital Partners's Rain Oncology Inc. Common Stock position peaked at $18.6M in Q1 2023.
  • 62 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q2 2023.

Based on Adage Capital Partners's 13F filing for Q2 2023, filed 14 Aug 2023.